Insulin-like growth factors (IGF-I and IGF-II) are mitogenic polypeptides expressed in both developing and adult tissues. To examine the effects of IGFs on neuronal growth, we used SH-SY5Y neuroblastoma cells as an in vitro model of nervous system development. In the current study, we found that either IGF-I (0.1 to 10 nM), insulin (0.1 to 5 #g/ml) or calf serum (0.1 to 3Yo) increased SH-SY5Y proliferation over a 3 day period in a dose dependent manner. In each case, treatment with anti-IGF-I receptor antibodies blocked cell proliferation. IGF-II mRNA levels correlated with SH-SY5Y cell density; subconfluent cells expressed high levels of IGF-II mRNA while low levels of IGF-II mRNA were present in confluent cells. Similarly, serum deprivation increased IGF-I receptor mRNA by 4-fold. Collectively, these results support the concept that an IGF/IGF-I receptor system at least partially mediates SH-SY5Y cell proliferation and suggests the importance of IGFs in regulating neuronal growth.
Introduction
The insulin-like growth factors (IGF-I and IGF-II) belong to a family of polypeptides which promotes neuronal growth and survival [ 1 ] . During development, high levels of IGF transcripts are present
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in the mammalian nervous system [2] . IGF-II can stimulate DNA synthesis and proliferation in fetal neuroblasts [3] [4] [5] and both IGF-I and IGF-II promote survival as well as vigorous neuritic outgrowth of cultured chick sensory and sympathetic neurons [4] . Like other polypeptides, effects of the IGFs are mediated through binding to specific receptors. The IGF-I receptor, with a strong homology to the insulin receptor, is a tetrameric protein with intrinsic tyrosine-kinase activity [6] . The IGF-II/mannose 6-phosphate (IGF-II/M6P) receptor has a unique monomeric structure with distinct binding sites for IGF-II and M6P and is responsible for lysosomal enzyme trafficking [7] . The growth promoting effects of the IGFs are mediated primarily via the IGF-I receptor [8] [9] [10] . The role of the IGF-II/M6P receptor in IGF signal transduction is less clear [8] .
Cloned SH-SY5Y neuroblastoma cells, believed to have arisen from neural crest cells [11 ] , provide a good model system for examining the growth promoting effects of IGFs. These cells express IGF-II but not IGF-I mRNA [12] and possess functional IGF receptors [13] [14] [15] . We have reported that SH-SY5Y cells undergo density dependent autocrine growth, and, within 24 h of serum deprivation, express increased levels of IGF-II mRNA followed by secretion of immunoreactive IGF-II protein [16] . Exogenous addition of IGF II enhances SH-SY5Y growth, while treatment with anti-IGF-II antibody or anti-IGF-I receptor antibody (~-IR 3) partially blocks autocrine growth [ 16, 17] .
In the current study, we have extended our inital observations on the regulation of SH-SY5Y growth. We report that insulin and IGF-I increase SH-SY5Y proliferation via the IGF-I receptor, and that this receptor partially mediates calf serum-stimulated growth. Furthermore, expression of the IGF-II and IGF-I receptor genes exhibit serum and density dependence. Our results provide further evidence that neuroblastoma cell growth is mediated via an IGF/ IGF-I receptor system. This work extends our knowledge of IGF growth-promoting mechanisms, and indicates that insulin and IGFs are important in autocrine and serum-stimulated neuroblastoma cell growth.
Materials and Methods
Cell culture flasks were purchased from Corning Glass Works (Corning, NY), and Costar (Cambridge, MA). Calf serum (CS) and Dulbecco's modified Eagle's medium (DMEM) were obtained from Gibco BRL (Gaithersburg, MD). Restriction enzymes were from Boehringer-Mannheim (Indianapolis, IN) and Gibco BRL. Polyclonal IgG against human IGF-I receptor (ct-IR3) was obtained from Oncogene Science (Uniondale, NY). IGF-I was purchased from Bachem (Torrance, CA). All other chemicals were purchased from Sigma Chemical Company (St. Louis, MO).
Cell culture
SH-SY5Y human neuroblastoma cells were generously provided by Dr. Stephen Fisher, University of Michigan Medical Center. Cells were subcultured in 75 cm 2 culture flasks in DMEM and 10~o CS, and maintained at 37°C in a humidified atmosphere with 10~o CO2. The medium was changed every 2-3 days.
Cell proliferation assay
Cells were washed twice with DMEM and plated at a density of 9.10 4 cells/cm 2 in 96-well plates in 100 #1 DMEM with or without CS, 1 #g/ml ~-IR 3, IGF-I (0.1, 1, 3, and 10 nM), or insulin (0.1, 1, 3, and 5/~g/ml). Cell proliferation was measured by using the MTT colorimetric assay as previously described [16, 18] . At each time point, 25 #1 of MTT (3 (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added (1 mg/ml) for a 2 h incubation at 37°C in a humidified atmosphere with 10~o CO2. Next, 100 /A lysis buffer (0.1 ml of 50~o dimethyl formamide, 20~o (w/v) SDS, pH 4.7) was added and the cells were incubated in the dark overnight. The absorbance (A) of each well was measured at a wavelength of 570-595 nm by a Bio-Rad Model 2550 EIA reader (Bio-Rad Laboratories, Melville, NY).
Northern analysis and cDNA probes
SH-SY5Y cells were plated ((2-16). 10 4 cells/cm 2 in T150 flasks) in DMEM and 10~o CS and grown for 2 days. The medium was then removed, the cells were washed twice in DMEM, and DMEM with or without 10~o CS was added. RNA was extracted either immediately (no media change) or 1, 2, or 3 days after this medium change. Northern analysis was performed as previously reported [12] . RNA (20 #g) was electrophoresed in formaldehydeagarose gels and transferred to Nytran membranes (Schleicher and Schuell, Keene, NH) and then successively hybridized with [32p]dCTP labeled ((0.1-10)" 108 cpm/ktg) cDNA probes for either the human IGF-I receptor (bases 1490-2737 encoding the ct and fl chains were excised with Eco RI and Hind III) [ 19] or human IGF-II (bases 1-854 of a cDNA encoding exons 7, 8, and part of 9 excised with Pst I) [20] , and chicken fl-actin (1.8 kb was excised with Pst I) [21] . Densitometry was done and the relative A for each hybridization was calculated by averaging several exposures that were within the linear range of the film. These values were expressed as a percentage of untreated (day 0) controls and were then divided by a percentage of control values similarly obtained for/?-actin hybridizations. 
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Results
Effects of IGF-I and insulin on cell proliferation
To examine the effects of IGF-I and insulin on SH-SY5Y proliferation, cells were plated in DMEM with and without IGF-I (0. 1, 1, 3, 10 nM) or insulin (0.1, 1, 3, 5 #g/ml) . In the presence of either IGF-I or insulin, the cells divided in a dose-dependent fashion between days 1-3 ( Figs. 1 and 2) . The maximal effects were with either 10 nM IGF-I (Fig. 1) or 5 #g/ml insulin (Fig. 2) 
Serum stimulated cell proliferation
We then examined serum regulated SH-SY5Y proliferation by growing cells in increasing concentrations of calf serum. Cell proliferation exhibited a serum dose-dependent response, i.e., higher concentrations of serum were correlated with higher numbers of cells (Fig. 3A) . To determine what fraction of serum-stimulated growth was mediated via the IGF-I receptor, SH-SY5Y cells were grown in 0.6% CS in the presence of the IGF-I receptor blocking antibody, ~-IR 3. ~-IR 3 completely blocked serum-free growth and, as early as day 1, ~-IR 3 inhibited cell proliferation when compared to serum-containing media alone (Fig. 3B) . However, unlike its effects on serum-free growth, ~-IR 3 did not completely block cell proliferation in the presence of serum (Fig. 3B) .
IGF-H and IGF-I receptor gene expression
We have previously reported that SH-SY5Y cells express three IGF-II transcripts, 1.8, 4.8 and 6.0 kb 
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in length [ 12] . In the current study, we analyzed the most abundant transcript, the 6.0 kb, as a representative measure of total IGF-II content. As previously reported [16] , IGF-II mRNA levels increased by 6-fold within 24 h after serum removal. We then determined the effects of cell density on IGF-II mRNA levels as shown in Fig. 4 . At the lowest density used (2.5.104 cells/cm 2, subconfluency), IGF-II mRNA increased 6-fold above untreated control. This effect was reduced at higher plating densities (4 or 8.104 cells/cm2), and there was no increase in IGF-II mRNA content at the highest density employed (16.104 cells/cm 2, confluency). Thus, IGF-II mRNA increases after 1 day in serum-free media, but only at low (subconftuent) cell densities. As previously reported, Northern analysis of total cellular RNA detected an 11 kb IGF-I receptor mRNA transcript [ 12] . We then tested the effects of serum removal on IGF-I receptor mRNA levels (Fig. 5) . For these experiments, cells were grown in serum for 2 days, then serum deprived for 1 day, followed by addition of serum for 1, 2, 3 or 4 days. 24 h of serum deprivation increased the expression of IGF-I receptor mRNA by 4-fold (Fig. 5) . Addition of serum to cells which had been initially serum deprived produced a mild, but consistent increase of IGF-I receptor mRNA compared to IGF-I receptor mRNA levels after 1 day of serum deprivation (Fig. 5) . The highest level of IGF-I receptor mRNA was detected after 1 day in serum-free media and then 4 days in serum (Fig. 5 ).
Discussion
We have previously shown that IGF-II mediates an autocrine growth loop in SH-SY5Y cells via the IGF-I receptor [17] . Serum deprivation increases SH-SY5Y production of IGF-II immunoreactive protein and mRNA [ 16] . Likewise, SH-SY5Y proliferation is stimulated by addition of exogenous IGF-II [ 16] and blocked by antibodies to IGF-II or the IGF-I receptor [ 16, 17] . In the current study, we have extended our observations on IGF-mediated SH-SY5Y growth by examining the growth-promoting effects of IGF-I and insulin.
Both IGF-I and insulin stimulated SH-SY5Y proliferation in a dose-dependent fashion. These effects were blocked by the antibody to the IGF-I receptor, suggesting that this receptor mediates the effects of IGF-I and insulin on SH-SY5Y proliferation. In agreement with our results, IGF-I has been shown to stimulate DNA synthesis and/or cell proliferation in primary neuronal [22] and oligodendrocyte cultures [23] , rat sympathetic neuroblasts [5] and two other neuroblastoma cell lines, rat B104 neuroblastoma cells [24] and human SK-N-AS neuroblastoma cells [ 10] . Similarly, insulin also acts as a mitogen and can increase DNA synthesis in fibroblasts [25] [26] [27] , mammary tumor [28] and human colon cancer cell lines [29] . Ishii and colleagues reported that insulin increased [3H]thymidine uptake in SH-SY5Y cells [30] and, independent of cellular proliferation, insulin and IGF-I stimulated neuritic outgrowth [30] [31] [32] and selectively enhanced neurofilament [33] and tubulin mRNA [34] .
In the present study, IGF-I-, insulin-and calf serum-stimulated increases in cell proliferation were mediated via the IGF-I receptor. These data support the concept that the growth-promoting effects of the IGFs and insulin occur primarily via the IGF-I receptor [8] . We found that only high concentrations of insulin stimulated SH-SY5Y cell proliferation. Similar results have been reported when insulin is used as a mitogen in non-neural cells [25] [26] [27] or when insulin is used as a component of chemically defined media [35] , implying insulin is acting via the IGF-I receptor. Similarly, as we have observed in SH-SY5Y cells [ 17] and E1-Badry and colleagues in SK-N-AS neuroblastoma cells [ 10] , IGF-II-stimulated neuroblastoma cell growth is also mediated via the IGF-I receptor. Collectively, these data suggest that cell proliferation can at least partially be mediated via an IGF/IGF-I receptor system. Interestingly, c~-IR 3 did not completely inhibit serumstimulated growth, supporting the concept that other mitogenic factors may be involved in SH-SY5Y cell growth [17] . Preliminary work from our laboratory indicates that epidermal growth factor (EGF) is at least one of the other mitogens involved in SH-SY5Y growth [36] .
We have previously speculated that IGF-II expression is up-regulated when SH-SY5Y cells are subconfluent and, conversely, down-regulated when cells reach confluency [ 16] . Such a pattern of IGF-II expression would suggest a feedback control mechanism on cell growth by factors in SH-SY5Y conditioned media. In support of this idea, we have recently reported that addition of serum to subconfluent cells can decrease IGF-II gene expression [37] . In the present study, we observed an inverse relationship between IGF-II mRNA expression and cellular density. After serum removal, subconfluent cells expressed high levels of IGF-II mRNA, while confluent cells expressed lower IGF-II mRNA levels. We propose that factors in the conditioned media of confluent cells, similar to factors present in serum [16, 37] , regulate an IGF/IGF-I receptor feedback control mechanism. One likely regulatory factor is IGF-II itself [ 16] , although further work is needed to confirm this speculation.
To further characterize the role of a potential IGF/ IGF-I receptor feedback mechanism on SH-SY5Y growth, we examined IGF-I receptor gene expression after serum deprivation and with serum supplementation. We speculated that, in parallel with IGF-II mRNA [ 16] , IGF-I receptor mRNA would be regulated by changes in serum concentrations. As previously observed [ 17] , we saw a 4-fold increase in IGF-I receptor mRNA after one day of serum deprivation. Similarly, we have also observed an increase in IGF-I receptor mRNA when cells were growth inhibited [ 38 ] . With serum addition, there was a small but consistent increase in IGF-I receptor mRNA. These results imply that IGF-I receptor gene expression, like IGF-II, is linked to cell proliferation. Subconfluent (i.e., serum-deprived) SH-SY5Y cells increased IGF-I receptor mRNA. The addition of serum allowed cells to approach confluency via IGF-I receptor mediated growth; thus, the expression of IGF-I receptor mRNA remained constant or slightly increased. Our findings are consistent with studies showing increased IGF-I receptor mRNA in phorbol ester-treated SH-SY5Y cells [39, 40] and suggest that IGF-I receptor gene expression is regulated by cell growth [17, 41, 42] .
In conclusion, our results support the concept that an IGF/IGF-I receptor system at least partially mediates SH-SY5Y cell proliferation. SH-SY5Y cell growth was stimulated by serum, insulin and IGF-I via the IGF-I receptor, which, like IGF-II, exhibited density and serum dependent gene expression. Collectively, our data suggest the importance of IGFs in regulating nervous system growth.
